Schonfeld Strategic Advisors LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1665241
NEW YORK, NY
Position in ALNY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$23,745,547
+$5,893,448 QoQ
Shares Held
71,767
+59.9% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Derivatives in ALNY
reported options exposure · as of Jun 30, 2024CallValue
$7,290,000
CallShares
30,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Schonfeld Strategic Advisors LLC holds $295,816,121 across 125 Biotechnology names. ALNY ranks #2 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,757,899 | $25,419,219 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
71,767 | $23,745,547 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
318,405 | $21,692,932 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
324,722 | $18,882,584 | |
| 5 | INBX |
Inhibrx Biosciences, Inc.
|
254,827 | $17,132,019 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
62,142 | $11,747,945 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
494,737 | $10,364,740 | |
| 8 | INSM |
INSMED Inc
|
56,056 | $9,166,277 |
All Filings in ALNY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,745,547 | 71,767 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,852,099 | 44,894 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,427,304 | 9,709 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $19,160,070 | 58,757 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $832,201 | 3,082 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $29,884,370 | 127,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,664,261 | 27,867 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,290,000 | 30,000 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $10,685,925 | 43,975 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $35,211,316 | 235,606 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $8,070,300 | 54,000 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $373,823 | 1,953 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,457,149 | 42,107 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $468,392 | 2,466 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,052,075 | 15,236 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $6,728,378 | 33,615 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $1,094,043 | 6,700 | Shares | Sole | 2022-05-16 | |
| 2021-06-30 | $3,215,455 | 18,968 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $1,143,639 | 8,100 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||